SpringerLink
Log in

Cardiovascular Disease

  • Chapter
  • First Online:
Clinical Molecular Diagnostics

Abstract

The cardiovascular system is the conveyor system of the body which consists of the heart, blood vessels, and the blood itself. The heart is a cone-shaped muscular organ that normally weighs between 230 to 340 g. A healthy adult heart is the size of your fist: about 12 cm long, 9 cm wide, and 6 cm thick. A fibrous pericardium, a double-walled sac, encloses the heart. The wall of the heart is made up of a special type of muscle called cardiac muscle, also called myocardium. The heart is divided into the right and left sides of the heart by cardiac septum. The left and right side each separated into two chambers, called atrium and ventricle, by bicuspid valve and tricuspid valve, respectively. Therefore, the four chambers of the heart contain the right atrium, left atrium, right ventricle, and left ventricle. Blood is received with the right atrium and left atrium from the rest of the body and the lungs, respectively. The right ventricle pumps blood to the lungs while the left ventricle pumps out blood to the rest of the body (Fig. 37.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72:2231–64.

    Article  PubMed  Google Scholar 

  2. Wu AHB, Christenson RH, Greene DN, et al. Clinical laboratory practice recommendations for the use of cardiac troponin in acute coronary syndrome: expert opinion from the academy of the American association for clinical chemistry and the task force on clinical applications of cardiac bio-markers of the international federation of clinical chemistry and laboratory medicine. Clin Chem. 2018;64:645–55.

    Article  CAS  PubMed  Google Scholar 

  3. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–77.

    Article  PubMed  Google Scholar 

  4. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267–315.

    Article  CAS  PubMed  Google Scholar 

  5. Williams BA. The clinical epidemiology of fatigue in newly diagnosed heart failure. BMC Cardiovasc Disord. 2017;17:122.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Jiang H, Ge J. Epidemiology and clinical management of cardiomyopathies and heart failure in China. Heart. 2009;95:1727–31.

    Article  CAS  PubMed  Google Scholar 

  7. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93:1137–46.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Inamdar AA, Inamdar AC. Heart failure: diagnosis, management and utilization. J Clin Med. 2016;5:62.

    Article  PubMed Central  CAS  Google Scholar 

  9. Goetze JP, Hansen LH, Terzic D, et al. Atrial natriuretic peptides in plasma. Clin Chim Acta. 2015;443:25–8.

    Article  CAS  PubMed  Google Scholar 

  10. Chow SL, Maisel AS, Anand I, et al. Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American heart association. Circulation. 2017;135:e1054–91.

    Article  CAS  PubMed  Google Scholar 

  11. Rose NR. Viral myocarditis. Curr Opin Rheumatol. 2016;28:383–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Cooper LT Jr. Myocarditis. N Engl J Med. 2009;360:1526–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Hufnagel G, Pankuweit S, Richter A, et al. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz. 2000;25:279–85.

    Article  CAS  PubMed  Google Scholar 

  14. Fung G, Luo H, Qiu Y, et al. Myocarditis. Circ Res. 2016;118:496–514.

    Article  CAS  PubMed  Google Scholar 

  15. Ozdemir O, Oguz D, Atmaca E, et al. Cardiac troponin T in children with acute rheumatic carditis. Pediatr Cardiol. 2011;32:55–8.

    Article  PubMed  Google Scholar 

  16. Ukena C, Kindermann M, Mahfoud F, et al. Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis. Clin Res Cardiol. 2014;103:743–51.

    Article  CAS  PubMed  Google Scholar 

  17. Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:2636–2648, 2648a–2648d.

    Google Scholar 

  18. Abrar S, Ansari MJ, Mittal M, et al. Predictors of mortality in paediatric myocarditis. J Clin Diagn Res. 2016;10:SC12–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Barfuss SB, Butts R, Knecht KR, et al. Outcomes of Myocarditis in Patients with Normal Left Ventricular Systolic Function on Admission. Pediatr Cardiol. 2019;40(6):1171–4.

    Article  PubMed  Google Scholar 

  20. Nishii M, Inomata T, Takehana H, et al. Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. J Am Coll Cardiol. 2004;44:1292–7.

    Article  CAS  PubMed  Google Scholar 

  21. Fu DG. Cardiac arrhythmias: diagnosis, symptoms, and treatments. Cell Biochem Biophys. 2015;73:291–6.

    Article  CAS  PubMed  Google Scholar 

  22. Kalisch-Smith JI, Ved N, Sparrow DB. Environmental risk factors for congenital heart disease. Cold Spring Harb Perspect Biol. 2020;12(3):a037234.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Sun R, Liu M, Lu L, et al. Congenital heart disease: causes, diagnosis, symptoms, and treatments. Cell Biochem Biophys. 2015;72:857–60.

    Article  CAS  PubMed  Google Scholar 

  24. Alter BP, Czapek EE, Rowe RD. Sweating in congenital heart disease. Pediatrics. 1968;41:123–9.

    CAS  PubMed  Google Scholar 

  25. Pelech AN. Evaluation of the pediatric patient with a cardiac murmur. Pediatr Clin N Am. 1999;46:167–88.

    Article  CAS  Google Scholar 

  26. Rohit M, Shrivastava S. Acyanotic and cyanotic congenital heart diseases. Indian J Pediatr. 2018;85:454–60.

    Article  PubMed  Google Scholar 

  27. Frank JE, Jacobe KM. Evaluation and management of heart murmurs in children. Am Fam Physician. 2011;84:793–800.

    PubMed  Google Scholar 

  28. Frank LH, Bradshaw E, Beekman R, et al. Critical congenital heart disease screening using pulse oximetry. J Pediatr. 2013;162:445–53.

    Article  PubMed  Google Scholar 

  29. Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31:2915–57.

    Article  PubMed  Google Scholar 

  30. Pierpont ME, Brueckner M, Chung WK, et al. Genetic basis for congenital heart disease: revisited: a scientific statement from the American heart association. Circulation. 2018;138:e653–711.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Trevisan P, Rosa RFM, Koshiyama DB, et al. Congenital heart disease and chromossomopathies detected by the karyotype. Revista Paulista de Pediatria. 2014;32:262–71.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Bachman KK, DeWard SJ, Chrysostomou C, et al. Array CGH as a first-tier test for neonates with congenital heart disease. Cardiol Young. 2015;25:115–22.

    Article  PubMed  Google Scholar 

  33. Goldmuntz E, Paluru P, Glessner J, et al. Microdeletions and microduplications in patients with congenital heart disease and multiple congenital anomalies. Congenit Heart Dis. 2011;6:592–602.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Kim DS, Kim JH, Burt AA, et al. Burden of potentially pathologic copy number variants is higher in children with isolated congenital heart disease and significantly impairs covariate-adjusted transplant-free survival. J Thorac Cardiovasc Surg. 2016;151:1147–1151 e1144.

    Google Scholar 

  35. Choi BG, Hwang SK, Kwon JE, et al. Array comparative genomic hybridization as the first-line investigation for neonates with congenital heart disease: experience in a single tertiary center. Korean Circ J. 2018;48:209–16.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Zahavich L, Bowdin S, Mital S. Use of clinical exome sequencing in isolated congenital heart disease. Circ Cardiovasc Genet. 2017;10:e001581.

    Article  PubMed  Google Scholar 

  37. Paige SL, Saha P, Priest JR. Beyond gene panels: whole exome sequencing for diagnosis of congenital heart disease. Circ Genom Precis Med. 2018;11:e002097.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Probst V, Denjoy I, Meregalli PG, et al. Clinical aspects and prognosis of Brugada syndrome in children. Circulation. 2007;115:2042–8.

    Article  PubMed  Google Scholar 

  39. Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10:1932–63.

    Article  PubMed  Google Scholar 

  40. Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8:1308–39.

    Article  PubMed  Google Scholar 

  41. van der Werf C, Wilde AA. Catecholaminergic polymorphic ventricular tachycardia: from bench to bedside. Heart. 2013;99:497–504.

    Article  PubMed  CAS  Google Scholar 

  42. Broendberg AK, Nielsen JC, Bjerre J, et al. Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations. Heart. 2017;103:901–9.

    Article  PubMed  Google Scholar 

  43. Sumitomo N. Current topics in catecholaminergic polymorphic ventricular tachycardia. J Arrhythm. 2016;32:344–51.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center of Laboratory Medicine, Bei**g Key Laboratory for Molecular Diagnostics of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases & Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Bei**g, People’s Republic of China

    Zhou Zhou & Yahui Lin

Authors
  1. Zhou Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yahui Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhou Zhou .

Editor information

Editors and Affiliations

  1. Department of Laboratory Medicine, The First Affiliated Hospital of Nan**g Medical University, Nan**g, China

    Shiyang Pan

  2. Department of General Surgery, The First Affiliated Hospital of Nan**g Medical University, Nan**g, China

    **hai Tang

Rights and permissions

Reprints and permissions

Copyright information

© 2021 People's Medical Publishing House Co. Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zhou, Z., Lin, Y. (2021). Cardiovascular Disease. In: Pan, S., Tang, J. (eds) Clinical Molecular Diagnostics. Springer, Singapore. https://doi.org/10.1007/978-981-16-1037-0_37

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-1037-0_37

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-1036-3

  • Online ISBN: 978-981-16-1037-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation